Use of High-Field Intraoperative Magnetic Resonance Imaging to Enhance the Extent of Resection of Enhancing and Nonenhancing Gliomas

Mohammadi, Alireza; Sullivan, T. Barrett; Barnett, Gene H.; Recinos, Violette Renard; Angelov, Lilyana; Kamian, Kambiz; Vogelbaum, Michael A.

doi:10.1227/neu.0000000000000278

Cited by 43 publications

(21 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Use of intraoperative MRI and intraoperative fluorescence-guided surgery with 5-ALA may potentially allow for more complete resection. 172,173 One exception is when CNS lymphoma is suspected; a biopsy should be performed before steroids are administered, and management should follow the corresponding pathway if the diagnosis is confirmed. When maximal resection is performed, the extent of tumor debulking should be documented with a postoperative MRI scan with and without contrast performed within 48 hours after surgery.…”

Section: Primary Treatmentmentioning

confidence: 99%

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Nabors

Portnow

Ahluwalia

et al. 2020

Journal of the National Comprehensive Cancer Network

352

238

View full text Add to dashboard Cite

The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas to metastatic brain disease. The involvement of an interdisciplinary team, including neurosurgeons, radiation therapists, oncologists, neurologists, and neuroradiologists, is a key factor in the appropriate management of CNS cancers. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice. This article describes NCCN Guidelines recommendations for WHO grade I, II, III, and IV gliomas. Treatment of brain metastases, the most common intracranial tumors in adults, is also described.

show abstract

Section: Primary Treatmentmentioning

confidence: 99%

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Nabors

Portnow

Ahluwalia

et al. 2020

Journal of the National Comprehensive Cancer Network

352

238

View full text Add to dashboard Cite

show abstract

“…Intra-operative MRI appears to be an important tool that allows neurosurgeons to maximize the extent of surgical resection of gliomas, particularly for lower grade (non-enhancing) tumors [17]. Many studies have shown various advantages of IoMRI in surgical management of brain tumors, including its safety [11, 15, 24–28].…”

Section: Introductionmentioning

confidence: 99%

Intraoperative Magnetic Resonance Imaging in Intracranial Glioma Resection: A Single-Center, Retrospective Blinded Volumetric Study

et al. 2015

View full text Add to dashboard Cite

“…Overall survival (OS) will depend on several factors including Karnofsky performance status (KPS), age, tumor extension, neurological deficit, molecular or genetic markers, extent of resection (EOR), and chemoradiation treatment [17,18]. It is established that one of the modifiable factors for survival in HGG is the EOR but also the residual tumor volume left after surgery [19][20][21]. Therefore, the current standard of care involves a multidisciplinary approach including maximal safe tumor cyto-reduction with subsequent chemotherapy and radiation [22].…”

Section: Litt In Gliomasmentioning

confidence: 99%

Laser thermal therapy in the management of high-grade gliomas

Avecillas-Chasín

Atik

Mohammadi

et al. 2020

International Journal of Hyperthermia

Self Cite

View full text Add to dashboard Cite

Laser interstitial thermal therapy (LITT) is a minimally invasive therapy that have been used for brain tumors, epilepsy, chronic pain, and other spine pathologies. This therapy is performed under imaging and stereotactic guidance to precisely direct the probe and ablate the area of interest using real-time magnetic resonance (MR) thermography. LITT has gained popularity as a treatment for glioma because of its minimally invasive nature, small skin incision, repeatability, shorter hospital stay, and the possibility of receiving adjuvant therapy shortly after surgery instead of several weeks as required after open surgical resection. Several reports have demonstrated the usefulness of LITT in the treatment of newly-diagnosed and recurrent gliomas. In this review, we will summarize the recent evidence of this therapy in the field of glioma surgery and the future perspectives of the use of LITT combined with other treatment strategies for this devastating disease.

show abstract

Use of High-Field Intraoperative Magnetic Resonance Imaging to Enhance the Extent of Resection of Enhancing and Nonenhancing Gliomas

Abstract: IoMRI enhances the extent of resection, particularly for nonenhancing gliomas.

Cited by 43 publications

References 50 publications

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Intraoperative Magnetic Resonance Imaging in Intracranial Glioma Resection: A Single-Center, Retrospective Blinded Volumetric Study

Laser thermal therapy in the management of high-grade gliomas

Contact Info

Product

Resources

About